ATE121388T1 - 3- oder 4-substituierte oxotremorin-derivate. - Google Patents

3- oder 4-substituierte oxotremorin-derivate.

Info

Publication number
ATE121388T1
ATE121388T1 AT90101248T AT90101248T ATE121388T1 AT E121388 T1 ATE121388 T1 AT E121388T1 AT 90101248 T AT90101248 T AT 90101248T AT 90101248 T AT90101248 T AT 90101248T AT E121388 T1 ATE121388 T1 AT E121388T1
Authority
AT
Austria
Prior art keywords
compounds
substituted
oxotremorine
derivatives
oxotremorine derivatives
Prior art date
Application number
AT90101248T
Other languages
English (en)
Inventor
Eugene John Trybulski
Richard Hermann Kramss
Herbert Joseph Brabander
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE121388T1 publication Critical patent/ATE121388T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
AT90101248T 1989-01-23 1990-01-22 3- oder 4-substituierte oxotremorin-derivate. ATE121388T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/300,447 US4937235A (en) 1989-01-23 1989-01-23 3- or 4-substituted oxotremorine derivatives

Publications (1)

Publication Number Publication Date
ATE121388T1 true ATE121388T1 (de) 1995-05-15

Family

ID=23159138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90101248T ATE121388T1 (de) 1989-01-23 1990-01-22 3- oder 4-substituierte oxotremorin-derivate.

Country Status (9)

Country Link
US (2) US4937235A (de)
EP (1) EP0381984B1 (de)
JP (1) JP2894358B2 (de)
AT (1) ATE121388T1 (de)
AU (1) AU622517B2 (de)
CA (1) CA2008107C (de)
DE (1) DE69018659T2 (de)
DK (1) DK0381984T3 (de)
ES (1) ES2070934T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089518A (en) * 1989-01-23 1992-02-18 American Cyanamid Company 3- or 4-substituted oxotremorine derivatives and a method of treating cholinergic dysfunction therewith
JP2834501B2 (ja) * 1989-11-25 1998-12-09 鐘淵化学工業株式会社 3,4―エポキシ酪酸エステルの製法および中間体
US5550257A (en) * 1991-04-24 1996-08-27 American Cyanamid Company Substituted oxotremorine derivatives
US5356885A (en) * 1991-04-24 1994-10-18 American Cyanamid Company Substituted oxotremorine derivatives and pharmaceutical use thereof
US5346910A (en) * 1992-06-03 1994-09-13 American Cyanamid Company Maleimide derivatives of oxotremorine
US5932745A (en) * 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245743A (en) * 1967-11-09 1971-09-08 Astra Ab Alkynyl lactams
US3856790A (en) 1970-01-06 1974-12-24 American Home Prod Cyclic amides of 1,4-diaminobut-2-yne
EP0009326A3 (de) * 1978-08-30 1980-04-16 Pfizer Limited Pyrrolylketo- und Aminosäuren und deren Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GR78370B (de) * 1981-12-24 1984-09-26 Delalande Sa
US4847284A (en) * 1988-03-23 1989-07-11 Merck & Co., Inc. Antifungal fermentation product and derivatives and compositions thereof
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine

Also Published As

Publication number Publication date
AU622517B2 (en) 1992-04-09
DE69018659D1 (de) 1995-05-24
US4952600A (en) 1990-08-28
DE69018659T2 (de) 1996-01-18
US4937235A (en) 1990-06-26
EP0381984B1 (de) 1995-04-19
JP2894358B2 (ja) 1999-05-24
DK0381984T3 (da) 1995-05-08
ES2070934T3 (es) 1995-06-16
AU4868490A (en) 1990-07-26
CA2008107A1 (en) 1990-07-23
JPH02229155A (ja) 1990-09-11
EP0381984A1 (de) 1990-08-16
CA2008107C (en) 1996-08-13

Similar Documents

Publication Publication Date Title
GR20010300006T1 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
NO178262C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksanoler
DK140996A (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetraflour-6-alkyl-benzoesyreforbindelser
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
FI885504A (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
DE3878627D1 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DK314487A (da) Benzoxepinderivat
ATE123024T1 (de) 4-aminopyridinderivate.
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
ATE131056T1 (de) Verwendung von 2,3,4,5-tetrahydro-1h-3- benzazepinen bei der behandlung von neurologischen störungen.
DK0381984T3 (da) 3- eller 4-substituerede oxotremorinderivater
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
DE69011054D1 (de) Substituierte cyclohexene mit zentraler Nervensystem-Wirkung.
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
DE3876114D1 (de) Benzodioxol-derivate, diese enthaltende zusammensetzungen und deren verwendung zur herstellung von medikamenten.
FI853229A0 (fi) Nya benzodiazepiner, foerfarande foer deras framstaellning och deras anvaendning.
DE69319356D1 (de) Thiolderivate von Gallensäure
DK65691D0 (da) 2-aminocarboxylsyre-derivater, deres fremstilling og anvendelse som laegemidler
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
ATE135910T1 (de) Verwendung von (1r,2r)-n-methyl-2-(3-pyridyl)-2- tetrahydrothiopyrancarbothioamid-1-oxid zur herstellung von arzneimitteln zur behandlung von koronarschwäche
ATE49964T1 (de) Benzodioxepane, verfahren zur herstellung und verwendung als heilmittel.
DE3887174D1 (de) Verfahren zur Herstellung von 2,3-Dihydro-1H-imidazolylalkoxyinden-Derivaten und ihren pharmazeutisch annehmbaren Salzen, und Zwischenprodukte hierfür.